AJMC Staff

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Coverage of peer-reviewed research from AJMC® in the healthcare and mainstream press.

A phase 1 study, presented at the 2017 American Society of Clinical Oncology Annual Meeting, found that including daratumumab can improve patient response to treatment in newly diagnosed multiple myeloma.

A partnership in the United Kingdom is studying the economic burden of rheumatoid arthritis, particularly the indirect costs of the disease and the need to measure the human burden.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Congress still has to reauthorize the Prescription Drug User Fee Act, and it can have big consequences for rare disease patients if there is a delay.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

An analysis of discontinuation in randomized controlled trials for chronic obstructive pulmonary disease (COPD) has determined the main factors causing patients to drop out of clinical trials. The results were published in the International Journal of COPD.